For help on how to get the results you want, see our search tips.
250 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Generic Remove Generic filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Pemetrexed Hospira (updated)
pemetrexed, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 19/11/2015,
, Revision: 10, Authorised, Last updated: 19/10/2020
-
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Teva (updated)
zoledronic acid, Fractures, Bone, Cancer
Date of authorisation: 16/08/2012,, Revision: 13, Authorised, Last updated: 19/10/2020
-
List item
Human medicine European public assessment report (EPAR): Bortezomib Hospira (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016,, Revision: 9, Authorised, Last updated: 19/10/2020
-
List item
Human medicine European public assessment report (EPAR): Tagrisso (updated)
osimertinib mesylate, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 01/02/2016,
, 
, Revision: 12, Authorised, Last updated: 16/10/2020
-
List item
Human medicine European public assessment report (EPAR): Praxbind (updated)
idarucizumab, Hemorrhage
Date of authorisation: 20/11/2015,, Revision: 8, Authorised, Last updated: 16/10/2020
-
List item
Human medicine European public assessment report (EPAR): Tegsedi (updated)
inotersen sodium, Amyloidosis
Date of authorisation: 05/07/2018,, , 
, Revision: 6, Authorised, Last updated: 16/10/2020
-
List item
Human medicine European public assessment report (EPAR): Fulvestrant Mylan (updated)
fulvestrant, Breast Neoplasms
Date of authorisation: 08/01/2018,, Revision: 4, Authorised, Last updated: 15/10/2020
-
List item
Human medicine European public assessment report (EPAR): Exviera (updated)
dasabuvir sodium, Hepatitis C, Chronic
Date of authorisation: 14/01/2015,, , Revision: 18, Authorised, Last updated: 13/10/2020
-
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Mylan (updated)
zoledronic acid, Fractures, Bone
Date of authorisation: 23/08/2012,, Revision: 10, Authorised, Last updated: 13/10/2020
-
List item
Human medicine European public assessment report (EPAR): Sildenafil Teva (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 30/11/2009,, Revision: 15, Authorised, Last updated: 13/10/2020
-
List item
Human medicine European public assessment report (EPAR): Darunavir Krka d.d. (updated)
darunavir, HIV Infections
Date of authorisation: 18/01/2018,, Revision: 5, Authorised, Last updated: 13/10/2020
-
List item
Human medicine European public assessment report (EPAR): Duloxetine Mylan (updated)
duloxetine, Neuralgia, Diabetic Neuropathies, Anxiety Disorders, Depressive Disorder, Major
Date of authorisation: 19/06/2015,, Revision: 12, Authorised, Last updated: 07/10/2020
-
List item
Human medicine European public assessment report (EPAR): Sildenafil ratiopharm (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 23/12/2009,, Revision: 17, Authorised, Last updated: 06/10/2020
-
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord (updated)
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,, , Revision: 4, Authorised, Last updated: 05/10/2020
-
List item
Human medicine European public assessment report (EPAR): Ivozall (updated)
clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/11/2019,, Revision: 1, Authorised, Last updated: 05/10/2020
-
List item
Human medicine European public assessment report (EPAR): Repaglinide Accord (updated)
repaglinide, Diabetes Mellitus, Type 2
Date of authorisation: 22/12/2011,, Revision: 6, Authorised, Last updated: 30/09/2020
-
List item
Human medicine European public assessment report (EPAR): Duloxetine Zentiva (updated)
duloxetine, Anxiety Disorders, Depressive Disorder, Major, Neuralgia, Diabetes Mellitus
Date of authorisation: 20/08/2015,, Revision: 7, Authorised, Last updated: 29/09/2020
-
List item
Human medicine European public assessment report (EPAR): Tolucombi (updated)
telmisartan, hydrochlorothiazide, Hypertension
Date of authorisation: 13/03/2013,, Revision: 9, Authorised, Last updated: 28/09/2020
-
List item
Human medicine European public assessment report (EPAR): Pemetrexed medac (updated)
pemetrexed, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 26/11/2015,, Revision: 6, Authorised, Last updated: 21/09/2020
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel / Acetylsalicylic acid Mylan (updated)
acetylsalicylic acid, clopidogrel hydrogen sulfate, Acute Coronary Syndrome, Myocardial Infarction
Date of authorisation: 09/01/2020,, Revision: 1, Authorised, Last updated: 21/09/2020
-
List item
Human medicine European public assessment report (EPAR): Voriconazole Hikma (previously Voriconazole Hospira) (updated)
voriconazole, Bacterial Infections and Mycoses, Aspergillosis, Candidiasis
Date of authorisation: 27/05/2015,, Revision: 8, Authorised, Last updated: 21/09/2020
-
List item
Human medicine European public assessment report (EPAR): Sildenafil Actavis
sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009,, Revision: 13, Authorised, Last updated: 18/09/2020
-
List item
Human medicine European public assessment report (EPAR): Bortezomib Sun
bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016,, Revision: 8, Authorised, Last updated: 17/09/2020
-
List item
Human medicine European public assessment report (EPAR): Arsenic trioxide Accord
Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 14/11/2019,, Revision: 2, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Tolura
telmisartan, Hypertension
Date of authorisation: 04/06/2010,, Revision: 9, Authorised, Last updated: 16/09/2020